Mårten Wigstøl • 1960 • Oslo • 12 roles • 10 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
C COMBRA INVEST AS	Managing Director/CEO	-	5,664	33.33 % indirectly
C CIMON MEDICAL AS	Managing Director/CEO	681,453	28,701,249	4.23 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
B BARRACUDA INVEST AS	Contact Person	1,128,572	7,588,936	100 % directly
C COMBRA INVEST AS	Board Member	-	5,664	33.33 % indirectly
B BRACOM AS	Chairman	239,141,231	50,061,087	18.82 % indirectly
E ERAZE OSLO AS	Board Member	5,935,639	-766,314	10.25 % indirectly
E ERAZE AS	Board Member	550,000	-4,752,562	10.25 % indirectly
K KEIMON MEDICAL AS	Chairman	350,000	706,250	5.58 % indirectly
L LYBE SCIENTIFIC AS	Chairman	2,147,701	5,200,642	4.87 % indirectly
C CIMON MEDICAL AS	Chairman	681,453	28,701,249	4.23 % indirectly
D DEFIBRIO AS	Board Member	-	66,709,074	1.22 % indirectly

Last update: Apr 4, 2024

Related industries5

Professional, scientific and technical activities
Information and communication
Human health and social work activities
Real estate activities
Manufacturing

Direct relationships5

JC
Jan Christian Sølve Ohlander Fosseidbråten1972
ERAZE OSLO AS, ERAZE AS
CL
Christina Myhre Lystad1991
ERAZE OSLO AS, ERAZE AS
GO
Geir Ove Kjesbu1967
DEFIBRIO AS, CIMON MEDICAL AS
EG
Erling Geir Iversen1964
BRACOM AS, COMBRA INVEST AS
LA
Leif Arne Matre1962
BRACOM AS, COMBRA INVEST AS

Shares owned by Mårten Wigstøl

Name	Share class	Total operating income	Total equity	Share
B BARRACUDA INVEST AS	Ordinære aksjer	1,128,572	7,588,936	100 % directly
C COMBRA INVEST AS		0	5,664	33.33 % indirectly
B BRACOM AS		239,141,231	50,061,087	18.82 % indirectly
B BRACOM MICROTRENCHING AS		29,016,781	532,344	17.13 % indirectly
E ERAZE OSLO AS		5,935,639	-766,314	10.25 % indirectly
E ERAZE AS		550,000	-4,752,562	10.25 % indirectly
K KEIMON MEDICAL AS		350,000	706,250	5.58 % indirectly
L LYBE SCIENTIFIC AS		2,147,701	5,200,642	4.87 % indirectly
C CIMON MEDICAL AS		681,453	28,701,249	4.23 % indirectly
D DEFIBRIO AS		0	66,709,074	1.22 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: May 24, 2024